Company Overview and News

134
Tracking David Tepper's Appaloosa Management Portfolio - Q2 2018 Update

2018-09-03 seekingalpha - 9
This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 08/14/2018. Please visit our Tracking David Tepper’s Appaloosa Management Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q1 2018.
PCG LRCX SYMC KMT CQP CNC VST XOP KEY NRGEO CFIN WPZ BSX CIWV HCA SYK AABA AMAT WMB SUM BTUUQ VNTR BAC TMUSP LNG TMUS OC NRG ALL BABA ETP CZR GOOGL WMIH TERP WFCNP MGM FB PAH AY TMO WDC NVDA GOOG BAC HUN AGN UBS WFC WMIHP GJT XPO CFG BTU ALLY MU VSTE URI DG ULSGF

11
Best Energy ETFs & Stocks of Last Week

2018-08-27 zacks - 1
U.S. crude bounced back nicely and recorded its weekly gain in two months ending their longest run of weekly losses since 2015. This is primarily thanks to the tightening supply outlook on the back of looming Iranian supply shortages, and a strike in the North Sea oil and gas fields amid rising U.S. oil production (see: all the Energy ETFs here). Trump has re-imposed tough economic sanctions against Iran this month and vowed to bring more damaging sanctions in November that will target Iran's port operators, as well as its energy, shipping and shipbuilding industries.
CRC BHI NOG BTE XOP LLEX

3
Global LNG Dynamics And The Outlook For U.S. Natural Gas

2018-08-24 seekingalpha - 3
This implies a large boost to overall demand for U.S. natural gas supply with LNG exports accounting for 10% of overall demand by 2020.
LNGLF LNGLY XOP TELL UNG LNG

9
Keep an Eye on These ETF Areas as US & China Plan Trade Meet

2018-08-21 zacks
Trade tensions between the United States and China have hit a fever pitch. On Aug 8, China announced 25% tariffs on U.S. imports worth another $16 billion in retaliation to the taxes to be imposed on an equal amount of imports by U.S. authorities starting Aug 23. The targeted commodities include crude oil, diesel, cars and coal.
MU BOE AMAT XTH XOP LVS QCOM INTC BA ITA CARZ

6
Everything Is Changing! Dump Old Economy Stocks Now (Kirk Spano)

2018-08-01 seekingalpha
The world is changing and the stock market is finally catching up. Kirk and Brian discuss where the dangers lie and where to look for opportunity.
ECA LMT CAT TWX CTL ECA XOP TWC

 
Aramco IPO Will Not Come To Market In 2019 - Or Will It?

2018-07-20 seekingalpha
The price of crude oil has been making higher lows and higher highs since February 2016 when nearby NYMEX crude oil fell to a low of $26.05, and active month Brent futures hit bottom at $27.11 per barrel.
GJV NWS NWSA XOP

11
The Zacks Analyst Blog Highlights: First Trust Nasdaq, PowerShares S&P, SPDR S&P Oil, iShares U.S. Oil and PowerShares Dynamic Energy

2018-05-23 zacks
Chicago, IL – May 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include First Trust Nasdaq Oil & Gas ETF (FTXN - Free Report) , PowerShares S&P SmallCap Energy Fund (PSCE - Free Report) , SPDR S&P Oil & Gas Exploration & Production ETF (XOP - Free Report) , iShares U.
TPOYY EQC MPX XOP TAPOF KMI EQCO IEO MRO TAP KMR CVB KMRFZ CMCO

139
Tap Oil with Best Energy ETFs & Stocks YTD

2018-05-22 zacks
Oil price has been on a solid run in the past couple of months with Brent hovering near $80 per barrel, the highest since 2014, and U.S. crude trading above $72 per barrel. The rally has been driven by several factors that point to a rebalancing of the oil market and increase in investors’ optimism. In particular, Iran and Venezuela are playing an important role in driving oil price higher. This is especially true as Donald Trump finally withdrew from the Obama-era 2015 nuclear deal and vowed to re-impose all the powerful economic sanctions against the OPEC nation within the deal as well as bring new ones.
TAPOF TPOYY DNR SDRL PFIE IEO XOP TAP PES AKAM

10
Should You Invest in the iShares U.S. Oil & Gas Exploration & Production ETF (IEO)?

2018-05-15 zacks
If you're interested in broad exposure to the Energy - Exploration segment of the U.S. equity market, look no further than the iShares U.S. Oil & Gas Exploration & Production ETF (IEO - Free Report) , a passively managed exchange traded fund launched on 05/01/2006.
COP GD IEO CSX XOP VLO FIDU EOG

17
ETFs & Stocks in Focus as Trump Reimposes Sanction on Iran

2018-05-09 zacks
After months of speculation, Donald Trump finally withdrew from the Obama-era 2015 nuclear deal reached between Iran and six major powers. It also vowed to reimpose all the "powerful economic sanctions” on the OPEC nation waivered within the deal as well as introduce new ones. The sanctions would be reinstated after wind-down periods of 90 and 180 days so that companies could pull out themselves from agreements with Iran to avoid U.
USO GULF CVX XOP UGA ITA

 
XOP / SPDR S&P Oil & Gas Exploration & Production ETF / BlackRock Inc. - null (Passive Investment)

2018-05-08 sec.gov
us78464a7303_050318.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) SPDR S&P Oil & Gas Exploration & Production ETF -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 78464A730 -------------------------------------------------------- (CUSIP Number) April 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *T
XOP

 
XOP / SPDR S&P Oil & Gas Exploration & Production ETF / BlackRock Inc. - null (Passive Investment)

2018-05-08 sec.gov
us78464a7303_050318.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) SPDR S&P Oil & Gas Exploration & Production ETF -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 78464A730 -------------------------------------------------------- (CUSIP Number) April 30, 2018 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *T
XOP

36
Should You Invest in the iShares U.S. Oil & Gas Exploration & Production ETF (IEO)?

2018-04-26 zacks
The iShares U.S. Oil & Gas Exploration & Production ETF (IEO - Free Report) was launched on 05/01/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Energy - Exploration segment of the U.S. equity market.
COP FMAT FDIS IEO XOP VLO ADM EOG

22
Construct Your Oil Portfolio: The Capital Appreciation Version

2018-04-23 seekingalpha - 2
This is Part 3 of a three-piece series aiming to take a long, hard look at how to go about building an oil stock portfolio that fits your personality.
PBEGF GST-A GST-B GST MVN HKRCP XOP GPRK CNNEF EGRGF ESTE CNE ROSEU HK AMR MDLNF JAG PENYF ROSE

4
Should You Invest in the iShares U.S. Oil & Gas Exploration & Production ETF (IEO)?

2018-04-19 zacks
Looking for broad exposure to the Energy - Exploration segment of the U.S. equity market? You should consider the iShares U.S. Oil & Gas Exploration & Production ETF (IEO - Free Report) , a passively managed exchange traded fund launched on 05/01/2006.
COP IEO GUSH XOP VLO EOG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to XOP / SPDR S&P Oil & Gas Exploration & Production ETF on message board site Silicon Investor.

NexOptic Technology Corp NexOptic Technology Corp NexOptic Technology Corp
CUSIP: 78464A730